Ranbaxy Laboratories, India's top drugmaker by sales, on Monday reported a quarterly profit compared with a loss in the year-ago quarter.
New Delhi-based Ranbaxy, in which Japan's Daiichi Sankyo owns a controlling stake, said its standalone fiscal third quarter ended September was Rs 1.86 billion ($40 million), compared with a loss of 3.53 billion a year earlier.
{{^htLoading}} {{/htLoading}}
Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.
Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.
Advertisement
{{/htLoading}}{{#usCountry}}